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A 57-year-old man was referred with progressive dyspnoea, chest tightness and atypical
chest pain. His history, clinical examination and investigations, including chest X-ray and
high-resolution computed tomography scan of the thorax are presented for analysis and
interpretation. His diagnosis, treatment and clinical course are then discussed as a
learning exercise.
& 2008 Elsevier Ltd. All rights reserved.Case report
A 57-year-old man was referred with a 2-year history of
progressive dyspnoea, associated with chest tightness and
non-speciﬁc chest pain. He denied any other respiratory
symptoms, including cough, wheeze, sputum production or
haemoptysis. Although born in Israel he had been a resident
in the UK for 16 years. He had no past medical history and
took no regular medication. He kept no pets and had no
known exposure to asbestos, but had worked in the frying
section of a chicken products factory for 13 years where he
was exposed to ﬂour dust, breadcrumbs and smoke from the
fryer—he had never used a protective mask. He had stoppedElsevier Ltd. All rights reserved.
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om (A. Talbot-Smith).smoking 28 years ago, prior to which he had smoked
occasional cigars at the weekends.
On examination he was afebrile, not clubbed and there
was no peripheral lymphadenopathy. His lungs were clear to
auscultation and oxygen saturation was 96% at room
temperature. Cardiovascular examination was unremark-
able. Spirometry showed an FEV1 of 3.53 l (113% of
predicted), FVC of 4.37 l (112% of predicted), FEV1/FVC
77% of predicted and a total lung transfer factor for carbon
monoxide of 7.87 (88% predicted).
Laboratory examinations revealed a normal differential full
blood count, urea and electrolytes, liver function tests and
bone biochemistry. Erythrocyte sedimentation rate, C-reactive
protein and angiotensin-coverting enzyme were all within the
normal range, and ANA, ANCA and rheumatoid factor auto-
antibodies were negative. Following a chest X-ray (Figure 1) he
underwent a high-resolution computed tomography (HRCT)
scan of the thorax (Figure 2). The presumptive diagnosis was
then conﬁrmed by video-assisted thoracoscopic lung biopsy.
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Figure 1 Chest X-ray.
Figure 2 High-resolution computed tomography scan of the
thorax.
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The chest X-ray (Figure 1) shows widespread reticulo-
nodular shadowing, predominantly affecting the lung bases.
HRCT scan of the thorax
The HRCT (Figure 2) shows diffuse interstitial lung disease,
with both a ‘line’ and a ‘nodular’ component. There is also
extensive pleural calciﬁcation, pericardial calciﬁcation and
calciﬁcation of the pleural surface of the diaphragm.
Diagnosis: Pulmonary alveolar microlithiasis.Clinical course
He was started on empirical treatment with a bispho-
sphonate, but discontinued this due to gastrointestinal side
effects. His condition has been slowly progressive—he
remains well but with signiﬁcant impairment of his exercise
tolerance.Discussion
Pulmonary alveolar microlithiasis is a condition of unknown
aetiology. It is characterised by the intra-alveolar accumu-
lation of calciﬁed concretions known as calcispherites, in
the context of a normal serum calcium concentration.1 It
typically presents with cough and dyspnoea late in the
course of disease, although incidental case ﬁnding during
radiographic examination is not uncommon. It has a high
prevalence in Turkey but has been reported worldwide.2
The chest X-ray features are of bilateral micronodular
calciﬁed densities, usually less than 1mm in diameter and
often concentrated in the lower zones due to the greater
lung volumes of the lower lobes. HRCT of the thorax
typically demonstrates micronodular calciﬁcations, along
the bronchovascular bundles, perilobular and subpleural
regions.3 Whilst these ﬁndings are characteristic the
diagnosis is conﬁrmed histologically—by ﬁnding microliths
in sputum, at bronchoalveolar lavage, or at lung biopsy.
Pulmonary alveolar microlithiasis is a slowly progressive
condition—as it progresses a restrictive lung defect with
impairment of lung diffusing capacity occurs. There is no
known therapeutic agent: Corticosteroids have not been
found to be effective and although the use of bispho-
sphonates has been described, their efﬁcacy is unproven.4 In
advanced cases assessment for bilateral lung transplantation
should be considered.
As the case illustrates, diffuse calciﬁcation in the lung and
pleura should alert the physician to the possibility of
pulmonary alveolar microlithiasis.Conﬂict of interest statement
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